Calcium and Korlym drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calcium (calcium) and Korlym (mifepristone). Common drug interactions include cough among females and adverse drug reaction among males.

The phase IV clinical study analyzes what interactions people have when they take Calcium and Korlym. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. eHealthMe is studying from 184,203 Calcium users. Check the latest studies of Calcium.

What is Korlym?

Korlym has active ingredients of mifepristone. eHealthMe is studying from 3,078 Korlym users. Check the latest studies of Korlym.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

78 people who take Calcium and Korlym together, and have interactions are studied.

What are the common drug interactions of Calcium and Korlym, by gender? *:

female:

Cough
Decreased activity
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Blood pressure increased
Dizziness
Vomiting
Blood glucose increased
Alopecia (absence of hair from areas of the body)
Somnolence (a state of near-sleep, a strong desire for sleep)

male:

Adverse drug reaction
Asthenia (weakness)
Urinary retention (the inability to completely or partially empty the bladder)
Death
Blood corticotrophin increased
Blood glucose decreased
Blood pressure increased
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Disturbance in attention
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

What are the common drug interactions of Calcium and Korlym, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Vaginal haemorrhage (vaginal bleeding)

40-49:

Dizziness
Oedema peripheral (superficial swelling)
Vomiting
Aggression
Alopecia (absence of hair from areas of the body)
Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
Blood potassium decreased
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hyperhidrosis (abnormally increased sweating)

50-59:

Myalgia (muscle pain)
Rash pruritic (redness with itching)
Somnolence (a state of near-sleep, a strong desire for sleep)
Wound
Abdominal discomfort
Abdominal pain
Biliary colic
Gallbladder disorder
Hypersensitivity
Pain

60+:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Pain
Atrioventricular block (heart block)
Facial bones fracture (bone fracture of face)
Fall
Foot fracture
Ulcer haemorrhage (bleeding ulcer)
Asthenia (weakness)
Blood thyroid stimulating hormone increased

What are the existing conditions these people have? *

Cushing's Syndrome (obesity, a rounded face, increased fat): 70 people, 89.74%
Pituitary-Dependent Cushing's Syndrome (pituitary dependent hypercortisolism): 5 people, 6.41%

* Approximation only. Some reports may have incomplete information.

Do you take Calcium and Korlym?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously